Errors in Self-Reports of Health Services Use: Impact on Alzheimer Disease Clinical Trial Designs.
CONCLUSIONS:: Use of self-report data in clinical trials of Alzheimer disease treatments may inflate sample size needs. Even when adequate power is achieved by increasing sample size, reporting errors can result in a biased estimate of the true effect size of the intervention.
PMID: 24845761 [PubMed - as supplied by publisher]
Source: Alzheimer Disease and Associated Disorders - Category: Psychiatry Tags: Alzheimer Dis Assoc Disord Source Type: research
More News: Alzheimer's | Clinical Trials | Databases & Libraries | Nurses | Nursing | Psychiatry | Study